Fresenius raises its full-year outlook due to the excellent first quarter and a better than originally expected operating performance for the remainder of the fiscal year 2024. Fresenius now expects ...

Biocartis (Mechelen, Belgium) announced an expansion of its collaboration with Merck Serono Middle East and Merck Saudi Ltd., both affiliates of Merck KGaA (“Merck”). The collaboration aims to improve ...

Patented Viventis light sheet solution enables detailed volumetric imaging to explore life in its entirety Wetzlar, Germany, May 7, 2024 Leica Microsystems, a leader in microscopy and scientific ...

ANNOUNCEMENT FOR EUROPEAN MEDICAL & PHARMACEUTICAL TRADE MEDIA AND EUROPEAN FINANCIAL MEDIA ONLYGOTHENBURG, SE / ACCESSWIRE / May 7, 2024 / IRLAB Therapeutics (STO:IRLAB-A) (FRA:6IRA) Gothenburg, ...

Seaport Therapeutics Adds Industry Veteran to Board of Directors and Makes Key Executive Appointments Denice Torres, J.D., former Board Member of Karuna Therapeutics and accomplished healthcare ...

TMC welcomes Simon Estcourt as new Chief Executive Officer (CEO) to spearhead next phase of developmentHampshire, UK — 7 May 2024TMC Pharma Services Ltd., an established global product development and ...

Celerion, a leading clinical research organization, specializing in early clinical research and bioanalytical services, today announced the appointment of Jo Goodman as vice president of bioanalytical ...

CLEVELAND, OH / ACCESSWIRE / May 7, 2024 / NovAccess Global Inc. (OTCQB:XSNX), a biomedical company developing novel immunotherapies for brain tumor patients, today announced the postponement of its ...

Twenty-five women dentists were selected for the exclusive business and leadership development program.NEWPORT BEACH, CA / ACCESSWIRE / May 7, 2024 / On April 5, 2024, a Glidewell selection committee ...

This agreement is the 4th Provincial Health Authority contract for Cloud DX remote patient monitoring (RPM) services, alongside Alberta, the Yukon and Prince Edward Island. News in Summary· After a ...

Moberg Pharma AB (OMX:MOB) hereby announces that MOB-015 has received national approvals for all countries included in the decentralized procedure. MOB-015 is thus approved for the treatment of mild ...

Dividend/ForecastM1 Kliniken AG: Supervisory Board approves 2023 annual financial statements. Dividend proposal of EUR 0.50 per share07-May-2024 / 16:28 CET/CESTDisclosure of an inside information acc ...